Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 4, 2026 · Item 5.07
Oruka Therapeutics, Inc.
6
Item 5.07
Jun 4, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Item 5.07 |
| Primary topic | Item 5.07 |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Oruka Therapeutics, Inc. filed this 8-K to disclose: ) 855 Oak Grove Avenue Suite 100 Menlo Park , California 94025 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 650 ) 606-7910 N/A (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obliga… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 2, 2026 |
| Accession number | 0001213900-26-065294 |
| Reported items | Item 5.07 See Analysis tab for workforce implications |
